NCT01163110 Study to Investigate the Therapeutic Role of RNA Fragments in Platelet Production During Chemotherapy Status COMPLETED Phase PHASE1
NCT01155713 Bioavailability and Food Effect Study of TKI258 (CSF Capsule vs. FMI Tablet) in Adult Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT01117623 Continuous Dosing of BAY73-4506 in Patients With Advanced Malignancies Status COMPLETED Phase PHASE1
NCT01105533 A Dose Finding Study Of A New Medication, PF-00337210 That Will Possibly Decrease Blood Supply To Tumors Status COMPLETED Phase PHASE1
NCT01104077 Family and Personal History of Malignancy in Intraductal Papillary Mucinous Neoplasm (IPMN) Status COMPLETED Phase N/A
NCT01092091 Study of Pegylated Human Recombinant Arginase for Liver Cancer (BCT-100-002) Status COMPLETED Phase PHASE1/PHASE2
NCT00988195 Study of Pegylated Human Recombinant Arginase for Liver Cancer Status COMPLETED Phase PHASE1
NCT00961831 Radiation Dosimetry, Metabolism, Safety, Tolerability and Positron Emission Tomography/Computed Tomography (PET/CT) Imaging With BAY 85-8050 in Healthy Volunteers and Patients Status COMPLETED Phase PHASE1
NCT00747292 Peri-Operative Management of Patients Undergoing Laparoscopic Colorectal Surgery Status UNKNOWN Phase PHASE1/PHASE2
NCT00695279 Long Term Follow Up Of Patients Who Have Received Gene Therapy Or Gene Marked Products Status COMPLETED Phase N/A
NCT00694356 Study of Dalotuzumab (MK-0646) in Adults With Solid Tumors (MK-0646-009) Status COMPLETED Phase PHASE1
NCT00694083 Study of Ridaforolimus (MK-8669) in Participants With Solid Tumors (MK-8669-003)(COMPLETED) Status COMPLETED Phase PHASE1
NCT00692159 Study of TRC102 in Combination With Pemetrexed in Cancer Patients Status COMPLETED Phase PHASE1
NCT00520299 Study of ADI-PEG 20 in Patients With Advanced Melanoma Status COMPLETED Phase PHASE1/PHASE2
NCT00505414 A Study to Evaluate the Effectiveness and Safety of CG5503 (Tapentadol) in the Treatment of Chronic Tumor Related Pain Compared With Placebo and Morphine Status TERMINATED Phase PHASE3
NCT00496353 MK2461 Phase I/II Study in Patients With Advanced Solid Tumors (MK-2461-002 AM1)(COMPLETED) Status COMPLETED Phase PHASE1/PHASE2